Synthetic Chemistry and Therapies - Drug Discovery Digest

BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies

The Pharma Data

JANUARY 27, 2021

TD-0148A is a potential novel new therapy to treat debilitating psychiatric disorders with high unmet need, such as treatment resistant severe depression and post-traumatic stress disorder.

FDA

FDA Synthetic Chemistry Assay Development Treatment

Following our pole star to a transformative collaboration

Dark Matter Blog

APRIL 8, 2020

I believe there are more than a hundred medicines, powerful new therapies that can impact millions of lives, to be developed from our platform, and I want to see as many of them as possible find their way to patients. Our Chinese CROs are back online and doing synthetic chemistry at a pre-pandemic pace.

RNA

RNA Small Molecule Synthetic Chemistry Science

AWS helps Pfizer accelerate drug development and clinical manufacturing

The Pharma Data

DECEMBER 4, 2021

“Pfizer’s goal with AWS is to expedite the processes for drug discovery and development in ways that can ultimately enhance patient experiences and deliver new therapies to market. Pfizer has an extensive collection of documents that contain valuable data from a variety of drug development processes.

Drug Development

Drug Development Small Molecule Synthetic Chemistry Drugs

BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies

Following our pole star to a transformative collaboration

AWS helps Pfizer accelerate drug development and clinical manufacturing

Stay Connected